{"url_path":"/sec/repl/8-k/2026-06-29/item-2-02","section_key":"item-2-02","section_title":"Item 2.02 ****Results of Operations and Financial Condition.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/1737953/0001104659-26-078511-index.html","accession_number":"0001104659-26-078511","cik":"0001737953","ticker":"REPL","issuer_name":"Replimune Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1737953/0001104659-26-078511-index.html","primary_entity_key":"0001737953","primary_entity_name":"Replimune Group, Inc."},"word_count":146,"has_tables":true,"body_markdown":"**Item 2.02****Results of Operations and Financial Condition.**\n\n \n\nOn June 29, 2026, Replimune\nGroup, Inc. (the “Company”) issued a news release announcing its financial results for the fourth fiscal quarter and year\nended March 31, 2026 and certain corporate updates. A copy of the news release is furnished as Exhibit 99.1 to this Current Report\non Form 8-K.\n\n \n\nIn accordance with General\nInstruction B.2 of Form 8-K, the information in Item 2.02 of this Current Report on Form 8-K, including Exhibit 99.1, shall\nnot be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange\nAct”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under\nthe Securities Act of 1933, as amended, or the Exchange Act, except as expressly stated by specific reference in such filing."}